Apigenin

Apigenin__Protein kinase inhibitor Topotecan (Hydrochloride)

Product Name Apigenin
Description

Protein kinase inhibitor

Purity >98%
CAS No. 520-36-5
Molecular Formula C15H10O5
Molecular Weight 270.2
Storage Temperature -20ºC
Shipping Temperature Shipped Ambient
Product Type Inhibitor
Solubility Soluble to 50 mM in DMSO
Source Synthetic
Appearance White Solid
SMILES C1=CC(=CC=C1C2=CC(=O)C3=C(C=C(C=C3O2)O)O)O
InChI InChI=1S/C15H10O5/c16-9-3-1-8(2-4-9)13-7-12(19)15-11(18)5-10(17)6-14(15)20-13/h1-7,16-18H
InChIKey KZNIFHPLKGYRTM-UHFFFAOYSA-N
Safety Phrases Classification: Harmful. May be harmful if inhaled, swallowed or absorbed through skin.
Safety Phrases:
S22 – Do not breathe dust
S24/25 – Avoid contact with skin and eyes
S36/37/39 – Wear suitable protective clothing, gloves and eye/face protection
Risk Phrases:
R68 – Possible risk of irreversible effects
Cite This Product Apigenin (StressMarq Biosciences Inc., Victoria BC CANADA, Catalog # SIH-249)

References PubMed ID::http://www.ncbi.nlm.nih.gov/pubmed/19114688

Alternative Names 5,7-Dihydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one
Research Areas Cancer, Apoptosis, Cancer Growth Inhibitors, Tyrosine Kinase Inhibitors
PubChem ID 5280443
Scientific Background Apigenin induces a process called autophagia (1). It is a potent inhibitor of CYP2C9, an enzyme responsible for the metabolism of many pharmaceutical drugs in the body (2). Apigenin has also been shown to reverse the adverse effects of cyclosporine (3).
References 1. Ruela-de-Sousa R.R., et al. (2010) Cell Death and Disease. 1(e19): 1-11.
2. Dayong S.I., et al. (2009) Drug Metabolism and Disposition. 37(3): 629-634.
3. Chakravarthi S., Wen C.F., Nagaraja H.S. (2009) J Anal Bio Sci. 32(4): 320-327.